A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Public ClinicalTrials.gov record NCT06037252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Tirzepatide Doses in Participants With Type 2 Diabetes and Obesity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes and obesity that are already taking metformin. The study will last for about 89 weeks.
Study identification
- NCT ID
- NCT06037252
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 414 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2023 (Actual)
- Primary completion
- Jan 8, 2026 (Actual)
- Completion
- Oct 2026 (Estimated)
- Last update posted
- Mar 23, 2026
2023 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Advancement Centers of Arizona | Phoenix | Arizona | 85044 | — |
| John Muir Physician Network Research Center | Concord | California | 94520 | — |
| Care Access - Sacramento | Sacramento | California | 95831 | — |
| Care Access - Aurora | Aurora | Colorado | 80012 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Retreat Medical Research | Miami | Florida | 33135 | — |
| American Research Centers of Florida | Pembroke Pines | Florida | 33027 | — |
| Alta Pharmaceutical Research Center | Norcross | Georgia | 30092 | — |
| AGILE Clinical Research Trials, LLC | Sandy Springs | Georgia | 30328 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | — |
| Integrated Clinical Trial Services, Inc. | West Des Moines | Iowa | 50265 | — |
| Accellacare - Wilmington - 1917 Tradd Court | Wilmington | North Carolina | 28401 | — |
| Velocity Clinical Research, Mt. Auburn | Cincinnati | Ohio | 45219 | — |
| Summit Headlands | Portland | Oregon | 97210 | — |
| Clinical Research Associates Inc | Nashville | Tennessee | 37203 | — |
| Juno Research | Houston | Texas | 77040 | — |
| Southern Endocrinology Associates | Mesquite | Texas | 75149 | — |
| Charlottesville Medical Research | Charlottesville | Virginia | 22911 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06037252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2026 · Synced Oct 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06037252 live on ClinicalTrials.gov.